| P50 | author | Chunzhi Zhang | Q91291964 |
| P2093 | author name string | Sai Liang | |
| | Wanli Yu | |
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| | A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 | Q24322196 |
| | MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators | Q24336898 |
| | Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism | Q24600173 |
| | miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression | Q24610377 |
| | An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma | Q24629145 |
| | The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website | Q24645514 |
| | IDH1 and IDH2 mutations in gliomas | Q24648948 |
| | miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells | Q24649056 |
| | Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 |
| | Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 |
| | Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 |
| | The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 |
| | Deletion of RDINK4/ARF enhancer: A novel mutation to "inactivate" the INK4-ARF locus | Q39422458 |
| | MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression | Q39450296 |
| | Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme | Q39606772 |
| | Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J | Q39651756 |
| | Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status | Q39756064 |
| | Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity | Q39776996 |
| | Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions | Q39848278 |
| | MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM. | Q39990148 |
| | Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest | Q39992760 |
| | Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR-75. | Q40122040 |
| | Contribution of Notch signaling activation to human glioblastoma multiforme. | Q40157837 |
| | Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. | Q40179252 |
| | TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells | Q40246842 |
| | Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma | Q40291239 |
| | MiR-429 induces apoptosis of glioblastoma cell through Bcl-2. | Q40381720 |
| | MiR-126 Regulates the ERK Pathway via Targeting KRAS to Inhibit the Glioma Cell Proliferation and Invasion | Q40999025 |
| | MicroRNA‑141 inhibits the self‑renewal of glioblastoma stem cells via Jagged1 | Q41059804 |
| | SDF1-CXCR4 Signaling Maintains Central Post-Stroke Pain through Mediation of Glial-Neuronal Interactions | Q41074630 |
| | TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells | Q41164260 |
| | A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK. | Q41325859 |
| | miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling. | Q41440890 |
| | Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system | Q41483751 |
| | Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase | Q41639273 |
| | MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma | Q41846503 |
| | MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. | Q42123071 |
| | Modulation of chemoresponsiveness to platinum-based agents by microRNAs in cancer | Q42215256 |
| | Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy | Q42288627 |
| | Serum microRNA profiling in patients with glioblastoma: a survival analysis | Q42317085 |
| | Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes | Q42371249 |
| | TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p | Q42378963 |
| | MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists | Q42380563 |
| | MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells | Q36561540 |
| | MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A | Q36642299 |
| | The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma. | Q36756817 |
| | MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints | Q36785139 |
| | Apoptosis signaling pathways and lymphocyte homeostasis | Q36852224 |
| | MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B. | Q36914209 |
| | At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy | Q36935749 |
| | Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity | Q37030916 |
| | Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration | Q37081036 |
| | PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis | Q37157031 |
| | MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells | Q37187706 |
| | miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma | Q37191655 |
| | Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells | Q37221453 |
| | Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression | Q37232935 |
| | MicroRNA 203 Modulates Glioma Cell Migration via Robo1/ERK/MMP-9 Signaling. | Q37253571 |
| | Overexpressed let-7a inhibits glioma cell malignancy by directly targeting K-ras, independently of PTEN | Q37268874 |
| | miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma | Q37475020 |
| | Bax/Bak activation in the absence of Bid, Bim, Puma, and p53. | Q37482805 |
| | The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients | Q37619766 |
| | MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1. | Q37636608 |
| | Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e | Q37641753 |
| | Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth | Q37658825 |
| | MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma | Q37694818 |
| | Autoreactive natural killer T cells: promoting immune protection and immune tolerance through varied interactions with myeloid antigen-presenting cells | Q37750917 |
| | Regulatory T cells in tumor immunity | Q37762224 |
| | TGF-beta1 interactome: metastasis and beyond. | Q37775435 |
| | Biomarkers downstream of RAS: a search for robust transcriptional targets | Q37780776 |
| | Targeting metabolic remodeling in glioblastoma multiforme | Q37840941 |
| | Evolutionary functional analysis and molecular regulation of the ZEB transcription factors | Q37986328 |
| | Ubiquitination in signaling to and activation of IKK. | Q37995681 |
| | The molecular profile of microglia under the influence of glioma | Q38008966 |
| | Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13. | Q38065873 |
| | Detection methods for microRNAs in clinic practice | Q38090212 |
| | Cell transfer therapy for cancer: past, present, and future | Q38205228 |
| | Glioma Stem Cells: Signaling, Microenvironment, and Therapy | Q26765854 |
| | Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies | Q26823118 |
| | Adeno-associated virus-mediated microRNA delivery and therapeutics | Q27005597 |
| | MGMT gene silencing and benefit from temozolomide in glioblastoma | Q27824832 |
| | Epithelial-mesenchymal transitions in tumour progression | Q27860487 |
| | Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation | Q28140810 |
| | Identification of CDK4 sequences involved in cyclin D1 and p16 binding | Q28244094 |
| | Extensive modulation of a set of microRNAs in primary glioblastoma | Q28263314 |
| | TGFβ signalling in context | Q28275410 |
| | microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma | Q28280337 |
| | MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3 | Q28564217 |
| | Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 |
| | Hypoxia--a key regulatory factor in tumour growth | Q29547318 |
| | New functions for the matrix metalloproteinases in cancer progression | Q29547738 |
| | Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis | Q29619677 |
| | Inflammation meets cancer, with NF-κB as the matchmaker | Q29620242 |
| | microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma | Q30407637 |
| | Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim. | Q30413140 |
| | miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma | Q30419258 |
| | Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells | Q30430077 |
| | MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes | Q30434616 |
| | microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma. | Q30570563 |
| | Recent developments in the use of chemotherapy in brain tumours. | Q33232219 |
| | Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6 | Q33648713 |
| | Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship | Q33719798 |
| | At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy | Q33732329 |
| | Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways | Q33764768 |
| | Cross-talk between miRNA and Notch signaling pathways in tumor development and progression | Q33801752 |
| | Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential | Q33825657 |
| | Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker | Q33839507 |
| | Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells | Q33858506 |
| | A ten-microRNA expression signature predicts survival in glioblastoma | Q33869822 |
| | NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts | Q33883897 |
| | 14-3-3 binding sites in the snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal differentiation | Q33951080 |
| | Tailoring to RB: tumour suppressor status and therapeutic response | Q34040108 |
| | MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway | Q35945582 |
| | PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop | Q35955191 |
| | miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells | Q36070278 |
| | VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling | Q36127410 |
| | MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma | Q36139783 |
| | miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2 | Q36210894 |
| | Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma | Q36232178 |
| | TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors | Q36235100 |
| | MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway | Q36278102 |
| | cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a | Q36300857 |
| | MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme | Q36347204 |
| | Heterogeneity and plasticity of T helper cells | Q36388771 |
| | Matrix metalloproteinases: changing roles in tumor progression and metastasis | Q36422976 |
| | Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p | Q36493809 |
| | NOTCH signaling as a novel cancer therapeutic target | Q36539533 |
| | miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas | Q36557234 |
| | P70S6K 1 regulation of angiogenesis through VEGF and HIF-1alpha expression | Q34083360 |
| | MiR-181b sensitizes glioma cells to teniposide by targeting MDM2. | Q34136136 |
| | Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines | Q34157966 |
| | Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. | Q34159409 |
| | MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras | Q34193764 |
| | Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme | Q34207182 |
| | MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma | Q34221882 |
| | MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme | Q34262423 |
| | TGFβ in T cell biology and tumor immunity: Angel or devil? | Q34276027 |
| | MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape | Q34365811 |
| | Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma | Q34381578 |
| | A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas | Q34427825 |
| | Tumor antigen-specific T helper cells in cancer immunity and immunotherapy | Q34433202 |
| | The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells | Q34490171 |
| | MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. | Q34575813 |
| | Activation of glioma cells generates immune tolerant NKT cells | Q34683179 |
| | Glioma cancer stem cells induce immunosuppressive macrophages/microglia | Q34992518 |
| | Downregulations of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. | Q34997130 |
| | Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM. | Q35017237 |
| | MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway | Q35051948 |
| | Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity | Q35163556 |
| | miR-135b contributes to the radioresistance by targeting GSK3β in human glioblastoma multiforme cells | Q35284695 |
| | miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma | Q35293772 |
| | 14-3-3 Proteins: diverse functions in cell proliferation and cancer progression | Q35566220 |
| | Deregulation of Snai2 is associated with metastasis and poor prognosis in tongue squamous cell carcinoma | Q35624074 |
| | Sumoylation of vimentin354 is associated with PIAS3 inhibition of glioma cell migration | Q35640113 |
| | A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy | Q35677134 |
| | HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway | Q35687115 |
| | miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells | Q35770894 |
| | Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors | Q35811255 |
| | MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2 | Q35832262 |
| | MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1. | Q35839826 |
| | VSIG4 is highly expressed and correlated with poor prognosis of high-grade glioma patients | Q35941343 |
| | LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma | Q38261762 |
| | Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells. | Q38321797 |
| | TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria | Q38325201 |
| | MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. | Q38336556 |
| | MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. | Q38353056 |
| | miR-19a and miR-19b overexpression in gliomas | Q38395794 |
| | MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT. | Q38692922 |
| | m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program | Q38710467 |
| | MiR-217 promoted the proliferation and invasion of glioblastoma by repressing YWHAG. | Q38719284 |
| | Effects of CDKN2A (p16INK4A/p14ARF) Over-Expression on Proliferation and Migration of Human Melanoma A375 Cells | Q38725224 |
| | Capn4 promotes epithelial-mesenchymal transition in human melanoma cells through activation of the Wnt/β-catenin pathway | Q38729493 |
| | Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression | Q38732546 |
| | Let-7g-5p inhibits epithelial-mesenchymal transition consistent with reduction of glioma stem cell phenotypes by targeting VSIG4 in glioblastoma | Q38737828 |
| | The renewed battle against RAS-mutant cancers | Q38740000 |
| | Immunotherapy and radiation in glioblastoma. | Q38752191 |
| | MicroRNA-34a inhibits cell proliferation and induces cell apoptosis of glioma cells via targeting of Bcl-2. | Q38771273 |
| | MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor | Q38787480 |
| | MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor | Q38789492 |
| | miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2. | Q38795514 |
| | MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-β1. | Q38807949 |
| | MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-β pathway | Q38810687 |
| | Upregulated miRNA-622 inhibited cell proliferation, motility, and invasion via repressing Kirsten rat sarcoma in glioblastoma | Q38817536 |
| | MicroRNA‑566 modulates vascular endothelial growth factor by targeting Von Hippel‑Landau in human glioblastoma in vitro and in vivo | Q38819321 |
| | miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2. | Q38820350 |
| | miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4. | Q38822348 |
| | MicroRNA-129-1 acts as tumour suppressor and induces cell cycle arrest of GBM cancer cells through targeting IGF2BP3 and MAPK1. | Q38824154 |
| | The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 |
| | miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met | Q38845681 |
| | Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme | Q38847371 |
| | Presentation of Two Cases with Early Extracranial Metastases from Glioblastoma and Review of the Literature. | Q38849886 |
| | Growth of glioblastoma is inhibited by miR-133-mediated EGFR suppression | Q38857175 |
| | miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma | Q38869719 |
| | miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression | Q38876901 |
| | Doxycycline inhibits leukemic cell migration via inhibition of matrix metalloproteinases and phosphorylation of focal adhesion kinase | Q42419112 |
| | TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients | Q42426054 |
| | Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth | Q42645448 |
| | New prospects on the NKG2D/NKG2DL system for oncology | Q42796257 |
| | Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. | Q43283510 |
| | Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline | Q43580249 |
| | Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin | Q44209275 |
| | MiR-26a enhances the radiosensitivity of glioblastoma multiforme cells through targeting of ataxia-telangiectasia mutated | Q45012413 |
| | miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1. | Q45044001 |
| | Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline | Q45270171 |
| | Anti-cancer effect of R3V6 peptide-mediated delivery of an anti-microRNA-21 antisense-oligodeoxynucleotide in a glioblastoma animal model | Q45855761 |
| | Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy | Q46532765 |
| | A Selective Cyclin-Dependent Kinase 4, 6 Dual Inhibitor, Ribociclib (LEE011) Inhibits Cell Proliferation and Induces Apoptosis in Aggressive Thyroid Cancer. | Q47202838 |
| | Inhibition of cancer cell migration with CuS@ mSiO2-PEG nanoparticles by repressing MMP-2/MMP-9 expression | Q47215416 |
| | Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer | Q47345855 |
| | Krüppel Like Factors Family Expression in Cervical Cancer Cells | Q47382515 |
| | Prognostic relevance of genetic alterations in diffuse lower-grade gliomas | Q47583690 |
| | Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4/AKT/EMT pathway in human glioblastoma cells | Q47638547 |
| | Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587. | Q47881690 |
| | Mesenchymal Stem Cells as Natural Bio-Factories for Exosomes Carrying miR-124a in the Treatment of Gliomas | Q48025819 |
| | Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy. | Q48134470 |
| | Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells | Q48135067 |
| | Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines | Q48154511 |
| | Macrophage migration inhibitory factor mediates viability and apoptosis of PVM/Ms through PI3K/Akt pathway | Q48202458 |
| | MicroRNA-520c inhibits glioma cell migration and invasion by the suppression of transforming growth factor-β receptor type 2. | Q48315466 |
| | MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Krüppel-like factor 4. | Q48545857 |
| | Radiogenomics to characterize regional genetic heterogeneity in glioblastoma | Q48582092 |
| | Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma | Q48616366 |
| | Immunocytochemical analysis of glomerular regionalization and neuronal diversity in the olfactory deutocerebrum of the spiny lobster | Q48797706 |
| | Aging and the Krüppel-like factors | Q49372792 |
| | The Wnt Transcriptional Switch: TLE Removal or Inactivation? | Q49693008 |
| | HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma | Q49724235 |
| | PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy. | Q49887901 |
| | Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors | Q49887919 |
| | Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53. | Q49920435 |
| | Ezh2 promotes clock function and hematopoiesis independent of histone methyltransferase activity in zebrafish | Q49977670 |
| | A 4-miRNAs signature predicts survival in glioblastoma multiforme patients. | Q50225594 |
| | Metformin inhibits TGF-β1-induced epithelial-to-mesenchymal transition-like process and stem-like properties in GBM via AKT/mTOR/ZEB1 pathway. | Q50327413 |
| | MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma. | Q50894719 |
| | miR-124 radiosensitizes human glioma cells by targeting CDK4. | Q50913359 |
| | Natural killer T cells: drivers or passengers in preventing human disease? | Q51828144 |
| | Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. | Q52855186 |
| | MAP kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma. | Q54227390 |
| | miR-101 acts as a tumor suppressor by targeting Kruppel-like factor 6 in glioblastoma stem cells. | Q54321491 |
| | Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways. | Q54499021 |
| | Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer. | Q54633524 |
| | Glioblastoma multiforme metastasis outside the CNS: three case reports and possible mechanisms of escape. | Q55461135 |
| | [Relationship between miR-218 and CDK6 expression and their biological impact on glioma cell proliferation and apoptosis]. | Q55462716 |
| | The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. | Q55463049 |
| | Role of connexin (gap junction) genes in cell growth control and carcinogenesis | Q60324708 |
| | [Changes in the functional status of the myocardium after left ventricular bypass] | Q71278768 |
| | Feedback circuitry between miR-218 repression and RTK activation in glioblastoma. | Q38878830 |
| | MicroRNA-320 inhibits cell proliferation in glioma by targeting E2F1. | Q38883624 |
| | miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2. | Q38893903 |
| | Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signature | Q38929512 |
| | MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein | Q38930784 |
| | MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG. | Q38940603 |
| | MiR-15b targets cyclin D1 to regulate proliferation and apoptosis in glioma cells | Q38978071 |
| | Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2. | Q39007403 |
| | miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways | Q39017914 |
| | A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo | Q39026399 |
| | miR-221/222 confers radioresistance in glioblastoma cells through activating Akt independent of PTEN status | Q39051241 |
| | TGF-β-induced miR10a/b expression promotes human glioma cell migration by targeting PTEN. | Q39084923 |
| | Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas | Q39099065 |
| | MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells | Q39124132 |
| | miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3. | Q39125450 |
| | LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2. | Q39126449 |
| | Celastrol inhibits TGF-β1-induced epithelial-mesenchymal transition by inhibiting Snail and regulating E-cadherin expression | Q39126470 |
| | Let-7b expression determines response to chemotherapy through the regulation of cyclin D1 in glioblastoma | Q39134240 |
| | microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells | Q39136340 |
| | Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme | Q39147552 |
| | miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1. | Q39156112 |
| | MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma. | Q39172188 |
| | Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2. | Q39198008 |
| | Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells | Q39198840 |
| | UBE2O negatively regulates TRAF6-mediated NF-κB activation by inhibiting TRAF6 polyubiquitination | Q39199690 |
| | miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells | Q39200427 |
| | P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2. | Q39230616 |
| | Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. | Q39281860 |
| | miR-92a is a critical regulator of the apoptosis pathway in glioblastoma with inverse expression of BCL2L11. | Q39296979 |
| | MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1. | Q39319071 |
| | MiR-410 regulates MET to influence the proliferation and invasion of glioma | Q39322020 |
| | The IL-10/STAT3 axis: Contributions to immune tolerance by thymus and peripherally derived regulatory T-cells | Q39385246 |
| | miR-221/222 is the regulator of Cx43 expression in human glioblastoma cells | Q39403463 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 452-474 | |
| P577 | publication date | 2018-09-04 | |
| P1433 | published in | NeuroMolecular Medicine | Q15716731 |
| P1476 | title | Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma | |
| P478 | volume | 20 | |